Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain
- PMID: 15193300
- DOI: 10.1016/j.nbd.2004.03.013
Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain
Abstract
The developing rodent brain is vulnerable to pharmacological blockade of N-methyl-d-aspartate (NMDA) receptors which can lead to severe and disseminated apoptotic neurodegeneration. Here, we show that systemic administration of the NMDA receptor antagonist MK801 to 7-day-old rats leads to impaired activity of extracellular signal-regulated kinase 1/2 (ERK1/2) and reduces levels of phosphorylated cAMP-responsive element binding protein (CREB) in brain regions which display severe apoptotic neurodegeneration. Impaired ERK1/2 and CREB activity were temporally paralleled by sustained depletion of neurotrophin expression, particularly brain-derived neurotrophic factor (BDNF). BDNF supplementation fully prevented MK801-induced neurotoxicity in immature neuronal cultures and transgenic constitutive activation of Ras was associated with marked protection against MK801-induced apoptotic neuronal death. These data indicate that uncoupling of NMDA receptors from the ERK1/2-CREB signaling pathway in vivo results in massive apoptotic deletion of neurons in the developing rodent brain.
Similar articles
-
Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity.Neurobiol Dis. 2004 Mar;15(2):177-87. doi: 10.1016/j.nbd.2003.10.006. Neurobiol Dis. 2004. PMID: 15006687
-
Tissue kallikrein alleviates glutamate-induced neurotoxicity by activating ERK1.J Neurosci Res. 2009 Dec;87(16):3576-90. doi: 10.1002/jnr.22151. J Neurosci Res. 2009. PMID: 19598250
-
Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.Neuroscience. 2005;132(4):1035-43. doi: 10.1016/j.neuroscience.2005.02.006. Neuroscience. 2005. PMID: 15857708
-
[NMDA receptor antagonist neurotoxicity and psychotomimetic activity].Masui. 2003 Jun;52(6):594-602. Masui. 2003. PMID: 12854473 Review. Japanese.
-
Glutamate signaling and the fetal alcohol syndrome.Ment Retard Dev Disabil Res Rev. 2001;7(4):267-75. doi: 10.1002/mrdd.1037. Ment Retard Dev Disabil Res Rev. 2001. PMID: 11754521 Review.
Cited by
-
Pediatric neurocritical care.Neurotherapeutics. 2012 Jan;9(1):3-16. doi: 10.1007/s13311-011-0093-6. Neurotherapeutics. 2012. PMID: 22183817 Free PMC article. Review.
-
Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain.Pharmacol Res Perspect. 2017 Aug;5(4):e00315. doi: 10.1002/prp2.315. Pharmacol Res Perspect. 2017. PMID: 28805973 Free PMC article.
-
NMDAR hypofunction and somatostatin-expressing GABAergic interneurons and receptors: A newly identified correlation and its effects in schizophrenia.Schizophr Res Cogn. 2017 Mar 9;8:1-6. doi: 10.1016/j.scog.2017.02.001. eCollection 2017 Jun. Schizophr Res Cogn. 2017. PMID: 28740825 Free PMC article. Review.
-
The dichotomy of NMDA receptor signaling.Neuroscientist. 2007 Dec;13(6):572-9. doi: 10.1177/10738584070130060401. Neuroscientist. 2007. PMID: 18000068 Free PMC article. Review.
-
Lovastatin inhibits the extracellular-signal-regulated kinase pathway in immortalized rat brain neuroblasts.Biochem J. 2007 Jan 1;401(1):175-83. doi: 10.1042/BJ20060731. Biochem J. 2007. PMID: 16952276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous